Suboxone Manufacturer’s Delayed-Release Buprenorphine Injections Show Promise at Maine Jail - FedKite: AI-Driven Solutions and Resources for Federal Inmates & Families

This topic is empty.

Viewing 0 reply threads

Author

Posts
- March 16, 2025 at 3:15 am #7713
  
  Kris Marker
  Keymaster
  
  Loaded on March 1, 2025
  
  published in Prison Legal News
  March, 2025, page 31
  
  Filed under:
  
  Medication,
  
  Drug/Alcohol Withdrawal,
  
  Drug Overdose,
  
  Drug Treatment/Rehab.
  
  Locations:
  
  Maine,
  
  Virginia.
  
  The stock price of Richmond, Virginia-based Indivior PLC was down 20% in the first 12 days of February 2025, after delayed approval from the federal Food & Drug Administration (FDA) of label changes on its Sublocade medication—a single injection that provides a 28-day extended-release dosage of buprenorphine for those recovering …
  
  Read more…
Author

Posts

Viewing 0 reply threads

You must be logged in to reply to this topic.